Phospholamban Cardiomyopathy: Unveiling a Distinct Phenotype Through Heart Failure Stages Progression

Circ Cardiovasc Imaging. 2022 Nov;15(11):e014232. doi: 10.1161/CIRCIMAGING.122.014232. Epub 2022 Sep 2.

Vanda Parisi^{1

2}, Chiara Chiti^{1

2}, Maddalena Graziosi^{1

3}, Ferdinando Pasquale^{1

3}, Raffaello Ditaranto^{1

2}, Matteo Minnucci^{1

2}, Mauro Biffi^{1

3}, Luciano Potena^{1

3}, Francesca Girolami⁴, Chiara Baldovini⁵, Ornella Leone⁵, Nazzareno Galiè^{1

2}, Elena Biagini^{1

3}

¹ Cardiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy (V.P., C.C., M.G., F.P., R.D., M.M., M.B., L.P., N.G., E.B.).
² Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Italy (V.P., C.C., R.D., M.M., N.G.).
³ European Reference Network for Rare, Low Prevalence, and Complex Diseases of the Heart (ERN GUARD-Heart), Italy (M.G., F.P., M.B., L.P., E.B.).
⁴ Cardiology Unit, Meyer Children's Hospital, Florence, Italy (F.G.).
⁵ Cardiovascular Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy (C.B., O.L.).

No abstract available

Keywords: cardiomyopathy; coronary artery disease; death, sudden, cardiac; gadolinium; hypertrophy.

Publication types